You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This book has two aims: to improve current perceptions of the role of economics in healthcare, and to explain the methodology of health economic evaluation.
This book provides a comprehensive history of the COVID-19 pandemic. At first glance, the pandemic struck as a natural disaster, with the sudden emergence of a virus as a major threat from outside. However, the pandemic has a history. SARS-COV-2 arrived in a world that was already very much focused on viruses, health, and longevity, and in which the fear of epidemics had already led to the mobilization of knowledge, technology, and a wide range of institutions to prepare us. The book develops the argument that these pre-existing structures and sensitivities have to a large extent determined the political and other reactions to the SARS-COV-2 virus and how the debates on the measures to halt its circulation have unfolded.
Explaining the innovative, radical, and aggressive approaches towards a more effective and efficient public health care, this definitive guide wraps up the series of seminars, workshops, and publications from CROSSTALKS--Vrije Universiteit Brussel's university and industry network that aims to bridge the gap between the academic and industrial world. This account examines the information gathered from 2005 to 2008 and discusses the contemporary challenges as well as the advances in medicine. Seeking to generate an open dialog about the world of health care, this compilation brings together voices from academic, political, corporate, and patient communities that want to engage in a collaborative exploration of the future of public health care.
Personalized and precision medicine (PPM)—the targeting of therapies according to an individual’s genetic, environmental, or lifestyle characteristics—is becoming an increasingly important approach in health care treatment and prevention. The advancement of PPM is a challenge in traditional clinical, reimbursement, and regulatory landscapes because it is costly to develop and introduces a wide range of scientific, clinical, ethical, and socioeconomic issues. PPM raises a multitude of economic issues, including how information on accurate diagnosis and treatment success will be disseminated and who will bear the cost; changes to physician training to incorporate genetics, probability an...
The lack of well-documented, factual information on fraud, waste and corruption in the healthcare sector is an important ally for those who would seek to abuse healthcare systems for their own profit. Our lack of knowledge of the incidence, nature and extent of fraud, waste and corruption in healthcare is a threat to the establishment of effective counter-fraud strategies. It prevents those who finance healthcare provision from understanding in clear and quantifiable terms the need to invest resources into counter-fraud activities. As a consequence, fraud remains a matter of moral hazard and healthcare systems continue to suffer considerable financial damage, as well as all the associated consequences for the quality of care that patients receive. It was for these reasons that the 'European Healthcare Fraud and Corruption Network' (EHFCN) and the 'Dutch Healthcare Authority' (NZa, member of EHFCN) decided to collaborate to publish this book... --
The pharmaceutical industry is almost boundless in its ability to supply new drug therapies, but how does one decide which are the best medicines to use within restricted budgets? With particular emphasis on modeling, methodologies, data sources, and application to real-world dilemmas, Pharmacoeconomics: From Theory to Practice provides an introduc
Analyzing the way managers plan for the construction of large infrastructure hubs, this study finds that failure to include all stakeholders at the start of a project hampers the timely completion of major projects--and in worst-case scenarios, implementation fails and major projects are shelved. Using new models of stakeholder theory, the discussion compares four case studies: the extension of DHL at Brussels National Airport; the industrial cluster on the Left Bank of the port of Antwerp; the plan for the port of Brussels, to be completed in 2015; and the plan for the port of Antwerp, to be completed in 2030.
This book provides a comprehensive examination of the pharmaceutical and medical device industry, including analysis of its current trade and innovation strategies. Opening with a survey of the global pharmaceutical and medical device industry, Bhardwaj outlines the growing trade and trade interdependence among countries in the global supply chain. He adopts a trade competitiveness approach to analyze patterns of product specialization and examines the drug discovery process and its challenges in translating bioscientific knowledge into lifesaving products. Bhardwaj argues that further economic integration, collaborative R&D, and digital technologies may help accelerate productivity and addr...
Any effort to gather evidence may prove pointless without ensuring its admissibility. Nevertheless, the EU, while developing instruments for smooth gathering of evidence in criminal matters, is not taking much effort to enhance its admissibility. Due to the lack of common rules in this matter, gathering and use of evidence in the EU cross-border context is still governed by the domestic law of the member states concerned. This may lead to situations where, given the differences between legal systems across the EU, evidence collected in one member state will not be admissible in other member states. Due to the fact that the Lisbon Treaty opened the possibility to adopt minimum rules concernin...